Literature DB >> 28215721

HER2 Transmembrane Domain Mutations: Rare New Target for Non-Small Cell Lung Cancer Therapy.

Hirotsugu Notsuda1, Penelope A Bradbury2, Ming-Sound Tsao3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28215721     DOI： 10.1016/j.jtho.2017.01.007

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  1 in total

1.  Clinical and molecular characteristics of Chinese non-small cell lung cancer patients with ERBB2 transmembrane domain mutations.

Authors:  Yun Fan; Jinrong Qiu; Ruoying Yu; Ran Cao; Xiaoxi Chen; Qiuxiang Ou; Xue Wu; Yang W Shao; Misako Nagasaka; Jiexia Zhang; Sai-Hong Ignatius Ou
Journal:  Mol Oncol       Date:  2020-07-01       Impact factor: 6.603
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.